# Novartis: portfolio, investments and team > Novartis is a vc firm based in Switzerland. 103 investments on record, 4 in the last 12 months, latest Sept 2026. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/novartis (Millionrounds; every figure on the page links to its filing or article) Switzerland · [Investor](https://millionrounds.com/investors) # Novartis Last cheque observed Sep 2026; 103 cheques on record. Deploying now VC firm Series A Venture Series B Analytics Healthcare Local Deploying now **21%** of best year **4** **cheques in 12 months**, 103 on record Since the last cheque **55** days **00** hrs **00** min **00** sec Median round **$37M** Rounds led **2 of 103** Sole investor **8 rounds** Exits **1 from the portfolio** Mostly in **United States, 63%** Pitch Novartis ## Novartis highlights - 01 4 cheques in the last 12 months - 02 Mostly Series A and Venture: 58% of its rounds - 03 Sole investor in 8 rounds, median $55M - 04 1 exits from the portfolio ## What they do - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Analytics Healthcare Local - **Based in:** Basel, Switzerland - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **103 appearances** - **2026** 3 rounds - **Sept** **[Intellia Therapeutics](https://millionrounds.com/company/intellia-therapeutics)** Debt · US **$400M** With 3 others - **Jul** **[Freenome](https://millionrounds.com/company/freenome)** US **$240M** With 4 others - **Apr** **[Patientory](https://millionrounds.com/company/patientory)** Venture · US **$500K** With 2 others - **2025** 15 rounds - **Dec** **[Relation Therapeutics](https://millionrounds.com/company/relation-therapeutics)** Venture · GB **$26M** With 5 others - **Oct** **[Deciphex](https://millionrounds.com/company/deciphex)** Debt · IE · Seroba Life Sciences **$18M** With 2 others - **Oct** **[Arcus Biosciences](https://millionrounds.com/company/arcus-biosciences)** US **$250M** With 3 others - **Oct** **[Rani Therapeutics](https://millionrounds.com/company/rani-therapeutics)** US **$60M** With 3 others - **Oct** **[C4 Therapeutics](https://millionrounds.com/company/c4-therapeutics)** US **$125M** With 3 others - **Oct** **[Adicet Bio](https://millionrounds.com/company/adicet-bio)** US **$80M** With 2 others - **Oct** **[Octave](https://millionrounds.com/company/octave)** Venture · US **Undisclosed** With 3 others - **Jun** **[IKAS Industrial Automation](https://millionrounds.com/company/ikas-industrial-automation)** Venture **Undisclosed** With 1 other - **Apr** **[Granite Bio](https://millionrounds.com/company/granite-bio)** Series B · US · Silicon Canals **$70M** With 3 others - **Mar** **[Octave](https://millionrounds.com/company/octave)** Series C · US **$32M** With 2 others - **Mar** **[Xealth](https://millionrounds.com/company/xealth)** Venture · US **Undisclosed** With 2 others - **Feb** **[Jiamai shares](https://millionrounds.com/company/jiamai-shares)** Venture **$14M** With 1 other - **Jan** **[Deciphex](https://millionrounds.com/company/deciphex)** Series C · IE · Seroba Life Sciences **$32M** With 9 others - **Jan** **[Rhygaze](https://millionrounds.com/company/rhygaze)** Series A · CH **$86M** With 2 others - **Jan** **[Alesta Therapeutics](https://millionrounds.com/company/alesta-therapeutics)** Series A · NL · Firms' own news pages **$67M** With 6 others - **2024** 15 rounds - **Dec** **[Citryll](https://millionrounds.com/company/citryll)** Series B · NL · Silicon Canals **$90M** *Led* - **Dec** **[Cleerly](https://millionrounds.com/company/cleerly)** Series C · US · TechCrunch **$106M** With 4 others - **Dec** **[Credence MedSystems](https://millionrounds.com/company/credence-medsystems)** Venture · US **$13M** With 1 other - **Dec** **[Borealis Biosciences](https://millionrounds.com/company/borealis-biosciences)** Series A · CA **$30M** With 1 other - **Oct** **[LOQUS23 THERAPEUTICS](https://millionrounds.com/company/loqus23-therapeutics)** Series A · GB **$46M** With 2 others - **Sept** **[ONL Therapeutics](https://millionrounds.com/company/onl-therapeutics)** Series D · US **$65M** With 1 other - **Sept** **[Epsilogen](https://millionrounds.com/company/epsilogen)** Series B · GB **$16M** With 2 others - **Sept** **[Aktis Oncology](https://millionrounds.com/company/aktis-oncology)** Series B · US **$175M** With 4 others - **Jul** **[Patientory](https://millionrounds.com/company/patientory)** Venture · US **Undisclosed** With 2 others - **Jul** **[Dren Bio](https://millionrounds.com/company/dren-bio)** Venture · US **$25M** With 4 others - **Jul** **[Parrots](https://millionrounds.com/company/parrots)** Grant · US **$20K** With 3 others - **Apr** **[FundaMental Pharma](https://millionrounds.com/company/fundamental-pharma)** Seed · DE **$2.9M** Sole investor - **Feb** **[Lightship](https://millionrounds.com/company/lightship)** Series C · US **$17M** With 1 other - **Jan** **[Aravax](https://millionrounds.com/company/aravax)** Series B · AU **$22M** With 3 others - **Jan** **[Enterprise Therapeutics](https://millionrounds.com/company/enterprise-therapeutics)** Series B · GB **$33M** With 3 others - **2023** 10 rounds - **Oct** **[Holmusk](https://millionrounds.com/company/holmusk)** Venture · SG **$30M** With 1 other - **Sept** **[Hyku](https://millionrounds.com/company/hyku)** Seed · US **$56M** With 3 others - **Aug** **[Poseida Therapeutics](https://millionrounds.com/company/poseida-therapeutics)** US **$50M** With 4 others - **Aug** **[Poseida Therapeutics](https://millionrounds.com/company/poseida-therapeutics)** US **$25M** With 4 others - **Jul** **[Caribou Biosciences](https://millionrounds.com/company/caribou-biosciences)** US **$125M** With 4 others - **Jul** **[TestCard](https://millionrounds.com/company/testcard)** Venture · GB **Undisclosed** With 2 others - **Jun** **[RxLightning](https://millionrounds.com/company/rxlightning)** Series A · US **$18M** With 2 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **64** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **2+** funds on file numbered funds in its name ## What they claim to have backed From their own portfolio page (on their website) **0** of 1 we have independently watched raise Live Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## Exits from the portfolio Companies it backed that were later bought or listed **1 in all** **[Lumenos](https://millionrounds.com/company/lumenos)** Bought by [Anthem Inc (former WellPoint, Inc.)](https://millionrounds.com/fund/anthem-inc-former-wellpoint-inc) **Undisclosed** May 2005 An exit counts when it came after the firm's first round in the company. From historical deal records. ## Companies it bought Acquisitions by the firm itself **Admune Therapeutics** **Undisclosed** Oct 2015 **[Spinifex Pharmaceuticals](https://millionrounds.com/company/spinifex-pharmaceuticals)** **$200M** Jun 2015 **[CoStim Pharmaceuticals](https://millionrounds.com/company/costim-pharmaceuticals)** **Undisclosed** Feb 2014 **[Corthera](https://millionrounds.com/company/corthera)** **$620M** Dec 2009 **[Protez Pharmaceuticals](https://millionrounds.com/company/protez-pharmaceuticals)** **$400M** Jun 2008 ## The cheque Series A Venture Series B Median round joined **$37M** the round, not its cheque Alone, median **$55M** Led 2 of 103 rounds **2%** - **Sole investor:** 8 rounds - **Last cheque:** Sept 2026 - **Exits:** 1 from the portfolio Rounds by stage said on their site - Series A *22* - Venture *20* - Series B *17* - Series C *10* - Debt *4* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) 6 - [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 6 - [Versant Ventures](https://millionrounds.com/fund/versant-ventures) 6 - [Atlas Venture](https://millionrounds.com/fund/atlas-venture) 4 - [Deerfield](https://millionrounds.com/fund/deerfield) 4 - [Fidelity](https://millionrounds.com/fund/fidelity) 4 **Pitching Novartis?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Novartis. A count of rooms they were both in, not a relationship either has claimed. [**Forbion Capital Partners** Private equity **6** rounds together](https://millionrounds.com/fund/forbion-capital-partners)[**RA Capital Management** Private equity **6** rounds together](https://millionrounds.com/fund/ra-capital-management)[**Versant Ventures** VC firm **6** rounds together](https://millionrounds.com/fund/versant-ventures)[**Atlas Venture** VC firm **4** rounds together](https://millionrounds.com/fund/atlas-venture)[**Deerfield** VC firm **4** rounds together](https://millionrounds.com/fund/deerfield)[**Fidelity** VC firm **4** rounds together](https://millionrounds.com/fund/fidelity)[**OrbiMed** Private equity **4** rounds together](https://millionrounds.com/fund/orbimed)[**Perceptive Advisors** Asset manager **4** rounds together](https://millionrounds.com/fund/perceptive-advisors)[**RTW Investments LLC** Growth equity **4** rounds together](https://millionrounds.com/fund/rtw-investments-lp)[**SR One** Corporate VC **4** rounds together](https://millionrounds.com/fund/sr-one)[**5AM Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/5am-ventures)[**Cormorant Asset Management** Private equity **3** rounds together](https://millionrounds.com/fund/cormorant-asset-management) ## Recently backed The latest companies Novartis put money into. [**Intellia Therapeutics** $400M · Sept 2026](https://millionrounds.com/company/intellia-therapeutics)[**Freenome** $240M · Jul 2026](https://millionrounds.com/company/freenome)[**Deciphex** $18M · Oct 2025](https://millionrounds.com/company/deciphex)[**Arcus Biosciences** $250M · Oct 2025](https://millionrounds.com/company/arcus-biosciences)[**C4 Therapeutics** $125M · Oct 2025](https://millionrounds.com/company/c4-therapeutics)[**Adicet Bio** $80M · Oct 2025](https://millionrounds.com/company/adicet-bio) ## Quick answers about Novartis ### What does Novartis invest in? Novartis invests most often at Series A and Venture (58% of the rounds on record), in sectors such as Analytics, Healthcare and Local. ### How active is Novartis? 103 investments on record, 4 of them in the last 12 months, and it led 2. The most recent was in Sept 2026. ### What has Novartis invested in recently? Its most recent investments on record: Intellia Therapeutics (Debt, Sept 2026), Freenome (Undisclosed round, Jul 2026) and Patientory (Venture, Apr 2026). ### How big are Novartis's cheques? The median round it joins is $37M. ### Does Novartis lead rounds? Sometimes: it led 2 of its 103 investments on record (2%). ### Where does Novartis invest? Most of the companies it backs are in the United States (63%), the United Kingdom (13%) and Ireland (5%). ### Is Novartis investing now? Yes: it is actively investing, with 4 investments in the last 12 months. ### Who does Novartis invest alongside? Most often Forbion Capital Partners (6 rounds together), RA Capital Management (6 rounds together) and Versant Ventures (6 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=novartis) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=novartis)